Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07615855

RIDECLAS: Delphi Classification of RICA Pathway Recommendations

RIDECLAS is an observational, prospective, non-interventional consensus study using a modified Delphi methodology. The study aims to obtain expert consensus on the classification and final formulation of recommendations for the RICA Pathway, an enhanced recovery pathway for adult surgery. Participants will be healthcare professionals with experience in enhanced recovery, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines. Experts will complete sequential online questionnaires. Individual responses will remain confidential, and aggregated anonymized feedback will be provided between Delphi rounds. The study does not involve patients, clinical interventions, biological samples, drugs, or medical devices.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Surgery

Zaragoza, 50009, Spain

Location contact

Grupo Español de Rehabilitacion Multimodal GERM SOCIEDAD CIENTIFICA

CONTACT

[email protected]

+34 636935065

About this study

This study will use a modified Delphi process conducted remotely through electronic questionnaires. A coordinating committee will prepare an initial list of recommendations based on the previous RICA Pathway document and updated evidence. Expert panelists will rate each recommendation using a 1-to-9 Likert scale and may provide free-text comments. Two Delphi rounds are planned, with a third round if needed for items without sufficient consensus or for reformulated statements. Between rounds, participants will receive aggregated and anonymized feedback, including measures of agreement, median scores, dispersion, and a summary of comments. Consensus for acceptance is predefined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Consensus for rejection is predefined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range. Items not meeting consensus criteria may be reassessed in subsequent rounds. The analysis will be descriptive and will include response rates, attrition between rounds, item-level agreement, median scores, interquartile ranges, and qualitative thematic review of comments.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthcare professional or researcher with relevant clinical or scientific experience in enhanced recovery pathways, perioperative medicine, surgery, anesthesiology, nursing, rehabilitation, or related disciplines.

At least 5 years of professional experience. Membership in GERM or participation in professional networks related to enhanced recovery in adult surgery.

Willingness to participate in the planned Delphi rounds. Provision of electronic informed consent.

Exclusion criteria

  • Failure to meet the predefined professional experience criteria. Failure to provide informed consent. Failure to complete the first Delphi round. Duplicate or incomplete responses that cannot be validated for analysis.

Treatment and study plan

Modified Delphi questionnaire

Other

Sequential online questionnaires used to rate and classify proposed RICA Pathway recommendations. This is not a clinical intervention and does not involve patient care, drugs, devices, or invasive procedures.

Primary outcomes

  1. Expert consensus on RICA Pathway recommendations

    Time frame: Through study completion, up to 7 months

    Consensus will be assessed for each recommendation using predefined Delphi criteria. Acceptance consensus will be defined as at least 75% of ratings in the 7-9 range and no more than 15% in the 1-3 range. Rejection consensus will be defined as at least 75% of ratings in the 1-3 range and no more than 15% in the 7-9 range.

Secondary outcomes

  1. Degree of agreement for each recommendation

    Time frame: After each Delphi round, up to 7 months.

    Distribution of ratings, median score, interquartile range, and percentage of ratings in predefined agreement/disagreement ranges.

  2. Stability of ratings between Delphi rounds

    Time frame: Between round 1 and round 2, and round 3 if performed, up to 7 months.

    Descriptive assessment of changes in item-level ratings and consensus status between rounds.

  3. Response rate and attrition between rounds

    Time frame: After each Delphi round, up to 7 months.

    Number and percentage of invited experts who complete each round, and percentage lost between rounds.

  4. Qualitative analysis of expert comments

    Time frame: After each Delphi round, up to 7 months.

    Thematic review of free-text comments to support item reformulation and interpretation of items without consensus.

Study contacts

Contact information is provided by the study sponsor or research team.

José-Manuel Ramírez Rodríguez, Professor of Surgery

CONTACT

[email protected]

+34 976 556400

Sponsors and collaborators

Lead sponsor

Universidad de Zaragoza

Other

Collaborators

  • Universidad Miguel Hernandez de Elche

Registry information

Official study title

Delphi Study for the Classification of Recommendations for the RICA Pathway (Enhanced Recovery in Adult Surgery)

Acronym: RIDECLAS

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 29, 2026
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.